Overview
Financial
Technicals
Analysis
Corporate Action
About
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
|
|
|
Bearish (17)
Neutral (4)
Bullish (6)
TLRY ROI
% from 52W High
52W Low: $0.59
13 Mar 2025
52W High: $2.85
03 Apr 2024
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions